Literature DB >> 10589033

Surgical treatment of lung metastases: prognostic factors for long-term survival.

N Abecasis1, F Cortez, A Bettencourt, C S Costa, F Orvalho, J M de Almeida.   

Abstract

BACKGROUND AND OBJECTIVES: Surgical resection of lung metastases is an established therapy for a large number of primary tumors, but there is some controversy about prognostic factors for long-term survival.
METHODS: From 1968 to 1996, we performed a retrospective review of a series of 85 patients (100 operations) that have been operated for resection of lung metastases. The Kaplan-Meier method was used to estimate the probabilities of survival, the log-rank test for the univariate analysis of prognostic factors for survival, and the Cox model in the subsequent multivariate analysis.
RESULTS: The operative mortality was 4% and the morbidity 18%. The mean follow-up after lung resection was 22.13 months (1-146). The actuarial 5-year survival rate was 29.2%. By univariate analysis, the following factors were associated with survival after resection: location and histology of the primary tumor, greatest dimension of the largest metastasis, radicality of the resection, involvement of the resection margins, and use of adjuvant therapy (P < 0.05). After multivariate analysis, only the dimension of the metastases and involvement of surgical margins have been found to be independently associated with survival.
CONCLUSIONS: Surgical excision is a safe and effective therapy for lung metastases from a large number of primary tumors, provided a complete resection is feasible. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10589033     DOI: 10.1002/(sici)1096-9098(199912)72:4<193::aid-jso3>3.0.co;2-8

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

Review 1.  Regional chemotherapy of the lung: transpulmonary chemoembolization in malignant lung tumors.

Authors:  Thomas J Vogl; Mohammad Shafinaderi; Stefan Zangos; Sebastian Lindemayr; Khashayar Vatankhah
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

2.  Transpulmonary chemoembolization (TPCE) as a treatment for unresectable lung metastases.

Authors:  Thomas J Vogl; Thomas Lehnert; Stephan Zangos; Katrin Eichler; Renate Hammerstingl; Huedayi Korkusuz; Sebastian Lindemayr
Journal:  Eur Radiol       Date:  2008-06-14       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.